| T-BSDB-H304 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (Tandem Diabody) |
Human |
Tandem Diabody |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| T-BSDB-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Tandem Diabody) |
Human |
Tandem Diabody |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| SCIGG-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (scIgG) |
Human |
Single chain IgGs |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| SCIGG-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (scIgG) |
Human |
Single chain IgGs |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| FVTIG-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (scFv4-Ig) |
Human |
scFv4-Ig |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| FVTIG-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (scFv4-Ig) |
Human |
scFv4-Ig |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSSG-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (scFv-IgG) |
Human |
scFv-IgG |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| BSSG-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (scFv-IgG) |
Human |
scFv-IgG |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| IGLFV-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (IgG(L)-scFv) |
Human |
IgG (L)-scFv |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| IGLFV-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (IgG(L)-scFv) |
Human |
IgG (L)-scFv |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSGV-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (IgG-Fv) |
Human |
IgG-Fv |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSGV-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (IgG-Fv) |
Human |
IgG-Fv |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSDG-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (Fv-IgG) |
Human |
Fv-IgG |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| BSDG-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Fv-IgG) |
Human |
Fv-IgG |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BABFV-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (F(ab')2-scFv2) |
Human |
F(ab')2-scFv2 |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| BABFV-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (F(ab')2-scFv2) |
Human |
F(ab')2-scFv2 |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| FABVC-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (Fab-scFv-Fc) |
Human |
Fab-scFv/sdAb-Fc |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| FABVC-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Fab-scFv-Fc) |
Human |
Fab-scFv/sdAb-Fc |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| SCDBC-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (scDiabody-CH3) |
Human |
scDiabody-CH3 |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| SCDBC-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (scDiabody-CH3) |
Human |
scDiabody-CH3 |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSDBC-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (Diabody-CH3) |
Human |
Diabody-CH3 |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| BSDBC-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Diabody-CH3) |
Human |
Diabody-CH3 |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| SCDBF-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (scDiabody-Fc) |
Human |
scDiabody-Fc |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| SCDBF-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (scDiabody-Fc) |
Human |
scDiabody-Fc |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSFVF-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (Tandem scFv-Fc) |
Human |
Tandem scFv-Fc |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| BSFVF-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Tandem scFv-Fc) |
Human |
Tandem scFv-Fc |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSDBF-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (Diabody-Fc) |
Human |
Diabody-Fc |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| BSDBF-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Diabody-Fc) |
Human |
Diabody-Fc |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSTF-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (scFv-Fc-scFv) |
Human |
scFv-Fc-scFv |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSTF-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (scFv-Fc-scFv) |
Human |
scFv-Fc-scFv |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSCFV-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (scFv-Fc) |
Human |
scFv-Fc |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSCFV-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (scFv-Fc) |
Human |
scFv-Fc |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| MNAB-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (Miniantibody) |
Human |
Miniantibody |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| MNAB-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Miniantibody) |
Human |
Miniantibody |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSFC-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (scFv-CH3) |
Human |
scFv-CH3 |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSFC-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (scFv-CH3) |
Human |
scFv-CH3 |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSCC-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (scFv-CH1/CL) |
Human |
scFv-CH1/CL |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSCC-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (scFv-CH1/CL) |
Human |
scFv-CH1/CL |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BIBD-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (Bibody) |
Human |
Bibody |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BIBD-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Bibody) |
Human |
Bibody |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| FABFV-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (Fab-Fv) |
Human |
Fab-Fv |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| FABFV-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Fab-Fv) |
Human |
Fab-Fv |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| MiniB-H306 |
Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (Minibody) |
Human |
Minibody |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| MiniB-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Minibody) |
Human |
Minibody |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| SCDB-H304 |
Recombinant Human Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| FABIG-H304 |
Recombinant Human Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| TRIB-H306 |
Recombinant Human Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Fab-scFv-scFv) |
Human |
Fab-scFv-scFv |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| BSIG-H304 |
Human Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| CROSSAB-H304 |
Recombinant Human Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| IGFV-H304 |
Recombinant Human Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| BSDB-H304 |
Recombinant Human Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| BSFAB-H304 |
Recombinant Human Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| BSFV-H304 |
Recombinant Human Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD89 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| SCDB-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| FABIG-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| TRIB-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Fab-scFv-scFv) |
Human |
Fab-scFv-scFv |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSIG-133 |
Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| CROSSAB-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| IGFV-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSDB-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSFAB-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSFV-133 |
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD89 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| CROSSAB-H305 |
Recombinant Human Anti-CD89 x Anti-Malaria Antigen Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD89 |
Human |
Malaria Antigen |
Human |
Inquiry |
| CROSSAB-H303 |
Recombinant Human Anti-CD89 x Anti-EGFR Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD89 |
Human |
EGFR |
Human |
Inquiry |
| CROSSAB-H299 |
Recombinant Human Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| CROSSAB-H259 |
Recombinant Human Anti-CD3 x Anti-HIV-1 gp41 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD3 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| CROSSAB-H220 |
Recombinant Human Anti-CD19 x Anti-CD89 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD19 |
Human |
CD89 |
Human |
Inquiry |
| IGFV-H305 |
Recombinant Human Anti-CD89 x Anti-Malaria Antigen Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD89 |
Human |
Malaria Antigen |
Human |
Inquiry |
| IGFV-H303 |
Recombinant Human Anti-CD89 x Anti-EGFR Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD89 |
Human |
EGFR |
Human |
Inquiry |
| IGFV-H299 |
Recombinant Human Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| IGFV-H259 |
Recombinant Human Anti-CD3 x Anti-HIV-1 gp41 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD3 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| IGFV-H220 |
Recombinant Human Anti-CD19 x Anti-CD89 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD19 |
Human |
CD89 |
Human |
Inquiry |
| BSDB-H305 |
Recombinant Human Anti-CD89 x Anti-Malaria Antigen Bispecific Antibody (Diabody) |
Human |
Diabody |
CD89 |
Human |
Malaria Antigen |
Human |
Inquiry |
| BSDB-H303 |
Recombinant Human Anti-CD89 x Anti-EGFR Bispecific Antibody (Diabody) |
Human |
Diabody |
CD89 |
Human |
EGFR |
Human |
Inquiry |
| BSDB-H299 |
Recombinant Human Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| BSDB-H259 |
Recombinant Human Anti-CD3 x Anti-HIV-1 gp41 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD3 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| BSDB-H220 |
Recombinant Human Anti-CD19 x Anti-CD89 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD19 |
Human |
CD89 |
Human |
Inquiry |
| BSFAB-H305 |
Recombinant Human Anti-CD89 x Anti-Malaria Antigen Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD89 |
Human |
Malaria Antigen |
Human |
Inquiry |
| BSFAB-H303 |
Recombinant Human Anti-CD89 x Anti-EGFR Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD89 |
Human |
EGFR |
Human |
Inquiry |
| BSFAB-H299 |
Recombinant Human Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| BSFAB-H259 |
Recombinant Human Anti-CD3 x Anti-HIV-1 gp41 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD3 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| BSFAB-H220 |
Recombinant Human Anti-CD19 x Anti-CD89 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD19 |
Human |
CD89 |
Human |
Inquiry |
| BSFV-H305 |
Recombinant Human Anti-CD89 x Anti-Malaria Antigen Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD89 |
Human |
Malaria Antigen |
Human |
Inquiry |
| BSFV-H303 |
Recombinant Human Anti-CD89 x Anti-EGFR Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD89 |
Human |
EGFR |
Human |
Inquiry |
| BSFV-H299 |
Recombinant Human Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| BSFV-H259 |
Recombinant Human Anti-CD3 x Anti-HIV-1 gp41 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD3 |
Human |
HIV-1 gp41 |
Human |
Inquiry |
| BSFV-H220 |
Recombinant Human Anti-CD19 x Anti-CD89 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD19 |
Human |
CD89 |
Human |
Inquiry |
| SCTB-103 |
Recombinant Anti-S. pneumoniae x Anti-CD89 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
S. pneumoniae |
Mouse |
CD89 |
Mouse |
Inquiry |
| SCTB-102 |
Recombinant Anti-Malaria Antigen x Anti-CD89 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
Malaria Antigen |
Mouse |
CD89 |
Mouse |
Inquiry |
| SCTB-101 |
Recombinant Anti-HIV-1 gp41 x Anti-CD89 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
HIV-1 gp41 |
Mouse |
CD89 |
Mouse |
Inquiry |
| SCTB-100 |
Recombinant Anti-EGFR x Anti-CD89 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
EGFR |
Mouse |
CD89 |
Mouse |
Inquiry |
| SCTB-095 |
Recombinant Anti-HIV-1 gp41 x Anti-CD64 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD64 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| SCTB-058 |
Recombinant Anti-HIV-1 gp41 x Anti-CD3 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD3 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| SCTB-020 |
Recombinant Anti-CD19 x Anti-CD89 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD19 |
Mouse |
CD89 |
Mouse |
Inquiry |
| SCDB-135 |
Recombinant Anti-CD89 x Anti-S. pneumoniae Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD89 |
Mouse |
S. pneumoniae |
Mouse |
Inquiry |
| SCDB-134 |
Recombinant Anti-CD89 x Anti-Malaria Antigen Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD89 |
Mouse |
Malaria Antigen |
Mouse |
Inquiry |
| SCDB-132 |
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD89 |
Mouse |
EGFR |
Mouse |
Inquiry |
| SCDB-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD64 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| SCDB-085 |
Recombinant Anti-CD3 x Anti-HIV-1 gp41 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD3 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| SCDB-045 |
Recombinant Anti-CD19 x Anti-CD89 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD19 |
Mouse |
CD89 |
Mouse |
Inquiry |
| FABIG-135 |
Recombinant Anti-CD89 x Anti-S. pneumoniae Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD89 |
Mouse |
S. pneumoniae |
Mouse |
Inquiry |
| FABIG-134 |
Recombinant Anti-CD89 x Anti-Malaria Antigen Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD89 |
Mouse |
Malaria Antigen |
Mouse |
Inquiry |
| FABIG-132 |
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD89 |
Mouse |
EGFR |
Mouse |
Inquiry |
| FABIG-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD64 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| FABIG-085 |
Recombinant Anti-CD3 x Anti-HIV-1 gp41 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD3 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| FABIG-045 |
Recombinant Anti-CD19 x Anti-CD89 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD19 |
Mouse |
CD89 |
Mouse |
Inquiry |
| TRIB-135 |
Recombinant Anti-CD89 x Anti-S. pneumoniae Bispecific Antibody (Fab-scFv-scFv) |
Human |
Fab-scFv-scFv |
CD89 |
Mouse |
S. pneumoniae |
Mouse |
Inquiry |
| TRIB-134 |
Recombinant Anti-CD89 x Anti-Malaria Antigen Bispecific Antibody (Fab-scFv-scFv) |
Human |
Fab-scFv-scFv |
CD89 |
Mouse |
Malaria Antigen |
Mouse |
Inquiry |
| TRIB-132 |
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Fab-scFv-scFv) |
Human |
Fab-scFv-scFv |
CD89 |
Mouse |
EGFR |
Mouse |
Inquiry |
| TRIB-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (Fab-scFv-scFv) |
Human |
Fab-scFv-scFv |
CD64 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| TRIB-085 |
Recombinant Anti-CD3 x Anti-HIV-1 gp41 Bispecific Antibody (Fab-scFv-scFv) |
Human |
Fab-scFv-scFv |
CD3 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| TRIB-045 |
Recombinant Anti-CD19 x Anti-CD89 Bispecific Antibody (Fab-scFv-scFv) |
Human |
Fab-scFv-scFv |
CD19 |
Mouse |
CD89 |
Mouse |
Inquiry |
| BSIG-135 |
Anti-CD89 x Anti-S. pneumoniae Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD89 |
Mouse |
S. pneumoniae |
Mouse |
Inquiry |
| BSIG-134 |
Anti-CD89 x Anti-Malaria Antigen Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD89 |
Mouse |
Malaria Antigen |
Mouse |
Inquiry |
| BSIG-132 |
Anti-CD89 x Anti-EGFR Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD89 |
Mouse |
EGFR |
Mouse |
Inquiry |
| BSIG-127 |
Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD64 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSIG-085 |
Anti-CD3 x Anti-HIV-1 gp41 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD3 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSIG-045 |
Anti-CD19 x Anti-CD89 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD19 |
Mouse |
CD89 |
Mouse |
Inquiry |
| CROSSAB-135 |
Recombinant Anti-CD89 x Anti-S. pneumoniae Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD89 |
Mouse |
S. pneumoniae |
Mouse |
Inquiry |
| CROSSAB-134 |
Recombinant Anti-CD89 x Anti-Malaria Antigen Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD89 |
Mouse |
Malaria Antigen |
Mouse |
Inquiry |
| CROSSAB-132 |
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD89 |
Mouse |
EGFR |
Mouse |
Inquiry |
| CROSSAB-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| CROSSAB-085 |
Recombinant Anti-CD3 x Anti-HIV-1 gp41 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD3 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| CROSSAB-045 |
Recombinant Anti-CD19 x Anti-CD89 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD19 |
Mouse |
CD89 |
Mouse |
Inquiry |
| IGFV-135 |
Recombinant Anti-CD89 x Anti-S. pneumoniae Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD89 |
Mouse |
S. pneumoniae |
Mouse |
Inquiry |
| IGFV-134 |
Recombinant Anti-CD89 x Anti-Malaria Antigen Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD89 |
Mouse |
Malaria Antigen |
Mouse |
Inquiry |
| IGFV-132 |
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD89 |
Mouse |
EGFR |
Mouse |
Inquiry |
| IGFV-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| IGFV-085 |
Recombinant Anti-CD3 x Anti-HIV-1 gp41 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD3 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| IGFV-045 |
Recombinant Anti-CD19 x Anti-CD89 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD19 |
Mouse |
CD89 |
Mouse |
Inquiry |
| BSDB-135 |
Recombinant Anti-CD89 x Anti-S. pneumoniae Bispecific Antibody (Diabody) |
Human |
Diabody |
CD89 |
Mouse |
S. pneumoniae |
Mouse |
Inquiry |
| BSDB-134 |
Recombinant Anti-CD89 x Anti-Malaria Antigen Bispecific Antibody (Diabody) |
Human |
Diabody |
CD89 |
Mouse |
Malaria Antigen |
Mouse |
Inquiry |
| BSDB-132 |
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Diabody) |
Human |
Diabody |
CD89 |
Mouse |
EGFR |
Mouse |
Inquiry |
| BSDB-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSDB-085 |
Recombinant Anti-CD3 x Anti-HIV-1 gp41 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD3 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSDB-045 |
Recombinant Anti-CD19 x Anti-CD89 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD19 |
Mouse |
CD89 |
Mouse |
Inquiry |
| BSFAB-135 |
Recombinant Anti-CD89 x Anti-S. pneumoniae Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD89 |
Mouse |
S. pneumoniae |
Mouse |
Inquiry |
| BSFAB-134 |
Recombinant Anti-CD89 x Anti-Malaria Antigen Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD89 |
Mouse |
Malaria Antigen |
Mouse |
Inquiry |
| BSFAB-132 |
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD89 |
Mouse |
EGFR |
Mouse |
Inquiry |
| BSFAB-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSFAB-085 |
Recombinant Anti-CD3 x Anti-HIV-1 gp41 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD3 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSFAB-045 |
Recombinant Anti-CD19 x Anti-CD89 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD19 |
Mouse |
CD89 |
Mouse |
Inquiry |
| BSFV-135 |
Recombinant Anti-CD89 x Anti-S. pneumoniae Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD89 |
Mouse |
S. pneumoniae |
Mouse |
Inquiry |
| BSFV-134 |
Recombinant Anti-CD89 x Anti-Malaria Antigen Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD89 |
Mouse |
Malaria Antigen |
Mouse |
Inquiry |
| BSFV-132 |
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD89 |
Mouse |
EGFR |
Mouse |
Inquiry |
| BSFV-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSFV-085 |
Recombinant Anti-CD3 x Anti-HIV-1 gp41 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD3 |
Mouse |
HIV-1 gp41 |
Mouse |
Inquiry |
| BSFV-045 |
Recombinant Anti-CD19 x Anti-CD89 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD19 |
Mouse |
CD89 |
Mouse |
Inquiry |
